4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-25-012304
CEO sold 30,000 shares at an average $26.75 ($802,484)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2025-01-30 | Sale 10b5-1 | −29,800 | $26.75 | $797,028 | 908,859 | D |
| Evans John M. CEO | 2025-01-30 | Sale 10b5-1 | −200 | $27.28 | $5,456 | 908,659 | D |
| Derivatives | |||||||
| Evans John M. CEO | 2025-01-31 | Grant or award · Stock Option (Right to Buy) 10b5-1 | +155,000 | 155,000 | D | ||
| Open-market sales · 30,000 sh · avg $26.75 · $802,484 | |||||||
Loading xslF345X05/ownership.xml…